Sukumaran, Vijayakumar <br/><br/>
Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress.  [electronic resource] 

 -  European journal of pharmacology  Feb 2011 
 - 126-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2010.10.081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Autoimmune Diseases--drug therapy<br/>Benzimidazoles--pharmacology<br/>Benzoates--pharmacology<br/>Blotting, Western<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Endomyocardial Fibrosis--drug therapy<br/>Enzyme-Linked Immunosorbent Assay<br/>Inflammation--drug therapy<br/>Male<br/>Myocarditis--drug therapy<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Inbred Lew<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Telmisartan